As you age, your body naturally makes less stomach acid and intrinsic factor
Fifth, previous CVOTs have suggested that the beneficial effects of GLP-1 RAs are primarily associated with long-acting agents such as liraglutide, semaglutide, and dulaglutide, rather than short-acting agents like exenatide and lixisenatide [17, 54, 56, 57, 68]
Novo Nordisc
While it shows promise for cognitive enhancement and neuroprotection, the lack of extensive research means that some potential risks may remain unknown
The GLP-1 Revolution: How Appetite-Suppressing Drugs Are Changing Diets and Disrupting the Food Industry From fewer chips to more yogurt, discover how Ozempic and Wegovy are reshaping grocery carts, dining habits, and consumer behavior
No controlled trials have tested this combination